2024 Q2 Form 10-Q Financial Statement

#000109355724000079 Filed on April 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.004B $921.0M
YoY Change 15.26% 24.21%
Cost Of Revenue $377.6M $359.1M
YoY Change 16.22% 28.76%
Gross Profit $626.7M $561.9M
YoY Change 14.7% 21.47%
Gross Profit Margin 62.4% 61.01%
Selling, General & Admin $332.7M $319.3M
YoY Change 11.91% 8.38%
% of Gross Profit 53.09% 56.83%
Research & Development $136.0M $141.5M
YoY Change 14.0% 18.91%
% of Gross Profit 21.7% 25.18%
Depreciation & Amortization $52.10M $52.50M
YoY Change 19.22% 26.2%
% of Gross Profit 8.31% 9.34%
Operating Expenses $468.7M $460.8M
YoY Change 12.05% 10.93%
Operating Profit $158.0M $101.1M
YoY Change 23.34% 114.19%
Interest Expense $31.40M $4.600M
YoY Change 0.64% 0.0%
% of Operating Profit 19.87% 4.55%
Other Income/Expense, Net $29.80M $31.40M
YoY Change -19.68% 43.38%
Pretax Income $187.8M $132.5M
YoY Change 17.89% 105.43%
Income Tax $44.30M -$13.90M
% Of Pretax Income 23.59% -10.49%
Net Earnings $143.5M $146.4M
YoY Change 23.81% 201.23%
Net Earnings / Revenue 14.29% 15.9%
Basic Earnings Per Share $0.36 $0.38
Diluted Earnings Per Share $0.35 $0.36
COMMON SHARES
Basic Shares Outstanding 397.7M shares 385.5M shares
Diluted Shares Outstanding 416.8M shares 416.7M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.969B $2.621B
YoY Change -18.34% 2.26%
Cash & Equivalents $939.2M $851.2M
Short-Term Investments $2.030B $1.770B
Other Short-Term Assets $48.40M $40.40M
YoY Change -74.53% -6.48%
Inventory $570.3M $589.1M
Prepaid Expenses $69.30M $59.40M
Receivables $945.2M $978.6M
Other Receivables $53.50M $6.200M
Total Short-Term Assets $4.848B $4.621B
YoY Change -3.09% 22.65%
LONG-TERM ASSETS
Property, Plant & Equipment $1.254B $1.177B
YoY Change 8.7% 9.4%
Goodwill $23.30M $23.20M
YoY Change -9.69% -9.73%
Intangibles $114.5M $123.3M
YoY Change -25.75% -24.63%
Long-Term Investments
YoY Change
Other Assets $82.90M $77.70M
YoY Change -82.87% 37.28%
Total Long-Term Assets $1.951B $1.862B
YoY Change 7.32% 6.46%
TOTAL ASSETS
Total Short-Term Assets $4.848B $4.621B
Total Long-Term Assets $1.951B $1.862B
Total Assets $6.799B $6.482B
YoY Change -0.32% 17.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $307.0M $269.7M
YoY Change 14.08% 1.31%
Accrued Expenses $1.400B $1.296B
YoY Change 37.5% 58.85%
Deferred Revenue $14.70M $16.40M
YoY Change 63.33% 70.83%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.722B $1.594B
YoY Change -16.79% -14.52%
LONG-TERM LIABILITIES
Long-Term Debt $2.496B $2.494B
YoY Change 0.27% 98.27%
Other Long-Term Liabilities $128.1M $129.4M
YoY Change -18.25% -0.23%
Total Long-Term Liabilities $128.1M $129.4M
YoY Change -95.16% -0.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.722B $1.594B
Total Long-Term Liabilities $128.1M $129.4M
Total Liabilities $4.365B $4.235B
YoY Change -7.53% 29.01%
SHAREHOLDERS EQUITY
Retained Earnings $1.311B $1.168B
YoY Change 103.49% 120.96%
Common Stock $1.992B $2.511B
YoY Change -12.19% 8.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.434B $2.247B
YoY Change
Total Liabilities & Shareholders Equity $6.799B $6.482B
YoY Change -0.32% 17.52%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $143.5M $146.4M
YoY Change 23.81% 201.23%
Depreciation, Depletion And Amortization $52.10M $52.50M
YoY Change 19.22% 26.2%
Cash From Operating Activities $279.4M $209.2M
YoY Change 46.82% 34.62%
INVESTING ACTIVITIES
Capital Expenditures $66.10M $56.90M
YoY Change 12.03% -23.83%
Acquisitions
YoY Change
Other Investing Activities -$122.8M -$2.300M
YoY Change -75.29%
Cash From Investing Activities -$188.9M $74.80M
YoY Change -66.02% -140.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.400M $4.700M
YoY Change -100.15% -58.04%
NET CHANGE
Cash From Operating Activities 279.4M $209.2M
Cash From Investing Activities -188.9M $74.80M
Cash From Financing Activities -1.400M $4.700M
Net Change In Cash 89.10M $284.9M
YoY Change -84.47% -1599.47%
FREE CASH FLOW
Cash From Operating Activities $279.4M $209.2M
Capital Expenditures $66.10M $56.90M
Free Cash Flow $213.3M $152.3M
YoY Change 62.45% 88.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
359100000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
278900000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
561900000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
462600000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
141500000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
119000000.0 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
319300000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
296400000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
460800000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
415400000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
101100000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
47200000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31400000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17300000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
132500000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
64500000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13900000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15900000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
146400000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
48600000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
390200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
386700000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
416700000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
418500000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
146400000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
48600000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-19200000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1400000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1400000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3700000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-20600000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5100000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
125800000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53700000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2068600000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
13400000 usd
CY2024Q1 dxcm Stock Issued During Period Value Achievement Of Milestone
StockIssuedDuringPeriodValueAchievementOfMilestone
0 usd
CY2024Q1 dxcm Stock Issued During Period Value Exercise And Settlement Of Warrants
StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants
0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39000000.0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-20600000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2246800000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2131800000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
12300000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35200000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
48600000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5100000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2233000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
48600000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
52500000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41600000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
39000000.0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
35200000 usd
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
1900000 usd
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
1500000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-41800000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9300000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
7800000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
13700000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5800000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-76600000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36700000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
59600000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-11400000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13400000 usd
CY2024Q1 dxcm Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
2000000.0 usd
CY2023Q1 dxcm Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
700000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
109600000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
86700000 usd
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-60700000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-39300000 usd
CY2024Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
3200000 usd
CY2023Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
1200000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
209200000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
155400000 usd
CY2024Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
992400000 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
809600000 usd
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1121800000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
697600000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
56900000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74700000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2300000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
74800000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-186700000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13400000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12300000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-8700000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1100000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4700000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11200000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3800000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1100000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
284900000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19000000.0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
567500000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
643300000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
852400000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
624300000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
851200000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
623200000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
1200000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
1100000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
852400000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
624300000 usd
CY2024Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
40700000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
55800000 usd
CY2024Q1 dxcm Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet
1100000 usd
CY2023Q1 dxcm Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet
1900000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
7400000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1000000.0 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div>
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
416700000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
418500000 shares
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div>
CY2024Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
10100000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7400000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7400000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
146400000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
48600000 usd
CY2024Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
2900000 usd
CY2023Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
1600000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
149300000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
50200000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
390200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
386700000 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8100000 shares
CY2022Q1 dxcm Shares Issued In Connection With The Restated Collaboration Agreement
SharesIssuedInConnectionWithTheRestatedCollaborationAgreement
2900000 shares
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
532500000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2045800000 usd
CY2024Q1 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
18300000 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2596600000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
315900000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2157800000 usd
CY2023Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
15200000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2488900000 usd
CY2023Q1 dxcm Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
0 usd
CY2024Q1 dxcm Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
0 usd
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2047200000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
400000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1800000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2045800000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2157400000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1300000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
900000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2157800000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1770000000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
275600000 usd
CY2023Q1 us-gaap Debt Instrument Term
DebtInstrumentTerm
P12M
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
2160000000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
301200000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
319500000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
49800000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
30000000.0 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
238100000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
210100000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
589100000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
559600000 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
59400000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
58700000 usd
CY2024Q1 dxcm Prepaid Inventory Current
PrepaidInventoryCurrent
31700000 usd
CY2023Q4 dxcm Prepaid Inventory Current
PrepaidInventoryCurrent
31500000 usd
CY2024Q1 dxcm Deferred Compensation Plan Assets Current
DeferredCompensationPlanAssetsCurrent
18300000 usd
CY2023Q4 dxcm Deferred Compensation Plan Assets Current
DeferredCompensationPlanAssetsCurrent
15200000 usd
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6200000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
13600000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
40400000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
49300000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
156000000.0 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
168300000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
1657600000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
1622500000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
549000000.0 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
509400000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1108600000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1113100000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
39800000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
38500000 usd
CY2024Q1 dxcm Long Term Deposits
LongTermDeposits
14400000 usd
CY2023Q4 dxcm Long Term Deposits
LongTermDeposits
14400000 usd
CY2024Q1 dxcm Other Long Term Assets
OtherLongTermAssets
23500000 usd
CY2023Q4 dxcm Other Long Term Assets
OtherLongTermAssets
22100000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
77700000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
75000000.0 usd
CY2024Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
269700000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
276400000 usd
CY2024Q1 dxcm Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
43000000.0 usd
CY2023Q4 dxcm Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
42600000 usd
CY2024Q1 dxcm Pharmacy Rebates
PharmacyRebates
1050100000 usd
CY2023Q4 dxcm Pharmacy Rebates
PharmacyRebates
950700000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7200000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12600000 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
11900000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7500000 usd
CY2024Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
18300000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
15200000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
46400000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
40500000 usd
CY2024Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1446600000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1345500000 usd
CY2024Q1 dxcm Accrued Wages Bonuses And Taxes Current
AccruedWagesBonusesAndTaxesCurrent
81300000 usd
CY2023Q4 dxcm Accrued Wages Bonuses And Taxes Current
AccruedWagesBonusesAndTaxesCurrent
139800000 usd
CY2024Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
29200000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
31200000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
110500000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
171000000.0 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
57600000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
58600000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7400000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7400000 usd
CY2024Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
15900000 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
15700000 usd
CY2024Q1 dxcm Other Tax Liabilities Noncurrent
OtherTaxLiabilitiesNoncurrent
43700000 usd
CY2023Q4 dxcm Other Tax Liabilities Noncurrent
OtherTaxLiabilitiesNoncurrent
38700000 usd
CY2024Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
4800000 usd
CY2023Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
5200000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
129400000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
125600000 usd
CY2024Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
36300000 usd
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
22300000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
4600000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
4600000 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
300000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
400000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31400000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17300000 usd
CY2024Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1900000 usd
CY2023Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2200000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1800000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1500000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
3700000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
3700000 usd
CY2018Q4 dxcm Number Of Initial Purchasers For Convertible Note Hedge Transactions
NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions
2 purchaser
CY2024Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
192400000 usd
CY2024Q1 dxcm Estimated Annual Effective Income Tax Rate Percent
EstimatedAnnualEffectiveIncomeTaxRatePercent
0.238
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.105
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39000000.0 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35200000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 dxcm Number Of Primary Geographic Markets
NumberOfPrimaryGeographicMarkets
2 primarymarket
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
921000000.0 usd
CY2024Q1 dxcm Revenue Percentage
RevenuePercentage
1
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
741500000 usd
CY2023Q1 dxcm Revenue Percentage
RevenuePercentage
1
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
921000000.0 usd
CY2024Q1 dxcm Revenue Percentage
RevenuePercentage
1
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
741500000 usd
CY2023Q1 dxcm Revenue Percentage
RevenuePercentage
1
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
dxcm-20240331_cal.xml Edgar Link unprocessable
0001093557-24-000079-index-headers.html Edgar Link pending
0001093557-24-000079-index.html Edgar Link pending
0001093557-24-000079.txt Edgar Link pending
0001093557-24-000079-xbrl.zip Edgar Link pending
dxcm-20240331.htm Edgar Link pending
dxcm-20240331.xsd Edgar Link pending
dxcm-20240331_g1.jpg Edgar Link pending
dxcm-20240331_g2.jpg Edgar Link pending
dxcm-20240331_g3.jpg Edgar Link pending
dxcm3312024exhibit3101.htm Edgar Link pending
dxcm3312024exhibit3102.htm Edgar Link pending
dxcm3312024exhibit3201.htm Edgar Link pending
dxcm3312024exhibit3202.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
dxcm-20240331_def.xml Edgar Link unprocessable
dxcm-20240331_lab.xml Edgar Link unprocessable
dxcm-20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dxcm-20240331_pre.xml Edgar Link unprocessable